الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 63 |  |  |
| | | from | 63 | | |
Abstract
A class of metabolic diseases known as diabetes are defined by hyperglycemia initiated by deficiencies in insulin action, secretion or both. Long-term complications of diabetes include the potential loss of vision, retinopathy, nephropathy, peripheral neuropathy, atherosclerotic cardiovascular disease, peripheral arterial disease, and cerebrovascular disease.
A notable diseased vascular consequence of diabetes is diabetic retinopathy, which also happens to be the most common cause of blindness in those who are at employed age.
Long-term diabetes, poorly controlled blood sugar, high blood pressure , the presence of dyslipidemia and diabetic nephropathy are all common risk factors for the development of diabetic retinopathy.
serum amyloid P and C-reactive protein (CRP) are parts of the pentraxin 3 (PTX3), a recognised member of the pentraxin superfamily. Unlike CRP, which is made by the liver, PTX3 is made by a range of cell types and tissues—most notably the vasculature—in response to inflammatory stimuli. (61)
PTX3 may act as a biomarker of inflammation by reflecting the local inflammatory condition in tissues.
The aim of the work is to compare serum pentraxin 3 in diabetic patients who have and who do not have retinopathy.
This study included 81 diabetics. All patients were subdivided into group A (41 Diabetics with retinopathy) and group B (40 Diabetics without retinopathy).
The subjects underwent a thorough clinical examination, which included a general examination and an ophthalmological examination.
Laboratory investigations including fasting blood glucose, HbA1C, Albumin to creatinine ratio, Lipid profile and Serum pentraxin 3 using Human Pentraxin 3 (PTX3) ELISA Kit (96T) were measured.
The study’s findings showed that:
• In this study, group A